1. Dihydroartemisinin inhibits ATP6 activity, reduces energy metabolism of hepatocellular carcinoma cells, promotes apoptosis and inhibits metastasis via CANX
   Jiang Chang et al, 2024, Oncology Letters CrossRef
2. Dihydroartemisinin Inhibits Epithelial–Mesenchymal Transition Progression in Medullary Thyroid Carcinoma Through the Hippo Signaling Pathway Regulated by Interleukin-6
   Ruicong Li et al, 2024, Cancer Biotherapy and Radiopharmaceuticals CrossRef
3. A state-of-art of underlying molecular mechanisms and pharmacological interventions/nanotherapeutics for cisplatin resistance in gastric cancer
   Jitendra Gupta et al, 2023, Biomedicine & Pharmacotherapy CrossRef
4. Adenosine Receptor A2B Antagonist Inhibits the Metastasis of Gastric Cancer Cells and Enhances the Efficacy of Cisplatin
   Honghong Wang et al, 2023, Technology in Cancer Research & Treatment CrossRef
5. Gestational Diabetes Mellitus Remodels the Fetal Brain Fatty Acid Profile Through Placenta-Brain Lipid Axis in C57BL/6J Mice
   Hai-Tao Yu et al, 2024, The Journal of Nutrition CrossRef
6. Relationship between Wnt/β-Catenin Signaling Pathway and Epithelial Mesenchymal Transformation Phenotype in Multiple Myeloma
   骁娜 姜, 2021, Advances in Clinical Medicine CrossRef
7. Wnt signaling in liver regeneration, disease, and cancer
   Gengyi Zou et al, 2023, Clinical and Molecular Hepatology CrossRef
8. Wnt/β-catenin Signaling in Lung Cancer: Association with Proliferation, Metastasis, and Therapy Resistance
   Maliheh Entezari et al, 2024, Current Cancer Drug Targets CrossRef